Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
5-Methylcytosine | 14 | 2021 | 146 | 3.240 |
Why?
|
Melanoma | 31 | 2024 | 5690 | 2.270 |
Why?
|
Cytosine | 5 | 2015 | 212 | 2.080 |
Why?
|
Skin Neoplasms | 27 | 2023 | 5824 | 1.810 |
Why?
|
Facial Transplantation | 12 | 2023 | 220 | 1.780 |
Why?
|
Graft Rejection | 27 | 2024 | 4498 | 1.160 |
Why?
|
Nevus | 3 | 2014 | 203 | 1.140 |
Why?
|
Nevus, Pigmented | 4 | 2017 | 222 | 1.080 |
Why?
|
Dioxygenases | 8 | 2021 | 354 | 1.000 |
Why?
|
Hair Follicle | 2 | 2024 | 222 | 0.930 |
Why?
|
Epigenesis, Genetic | 10 | 2019 | 3818 | 0.900 |
Why?
|
Sweat Gland Neoplasms | 2 | 2020 | 106 | 0.720 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2020 | 82 | 0.660 |
Why?
|
Precancerous Conditions | 2 | 2017 | 974 | 0.620 |
Why?
|
Skin | 14 | 2024 | 4474 | 0.610 |
Why?
|
Phthirus | 1 | 2016 | 1 | 0.540 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2021 | 8603 | 0.530 |
Why?
|
Sweat Gland Diseases | 1 | 2016 | 12 | 0.530 |
Why?
|
Cell Hypoxia | 1 | 2019 | 646 | 0.530 |
Why?
|
Lice Infestations | 1 | 2016 | 8 | 0.530 |
Why?
|
Ichthyosis, Lamellar | 1 | 2015 | 11 | 0.510 |
Why?
|
Lipoxygenase | 1 | 2015 | 71 | 0.500 |
Why?
|
Ascorbic Acid | 1 | 2019 | 657 | 0.500 |
Why?
|
Port-Wine Stain | 1 | 2014 | 33 | 0.470 |
Why?
|
Pyrrolizidine Alkaloids | 1 | 2014 | 10 | 0.470 |
Why?
|
Aristolochic Acids | 1 | 2014 | 13 | 0.470 |
Why?
|
Dermatitis | 1 | 2016 | 199 | 0.460 |
Why?
|
Facial Dermatoses | 1 | 2014 | 87 | 0.450 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2014 | 103 | 0.450 |
Why?
|
Codon, Nonsense | 1 | 2015 | 288 | 0.450 |
Why?
|
Graft vs Host Reaction | 1 | 2014 | 99 | 0.440 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 616 | 0.430 |
Why?
|
Skin Transplantation | 7 | 2022 | 1097 | 0.430 |
Why?
|
Carcinoma, Small Cell | 1 | 2015 | 420 | 0.430 |
Why?
|
Proto-Oncogene Proteins | 7 | 2021 | 4520 | 0.420 |
Why?
|
DNA-Binding Proteins | 11 | 2021 | 9594 | 0.420 |
Why?
|
Carcinogens | 1 | 2014 | 451 | 0.390 |
Why?
|
Mouth Neoplasms | 1 | 2017 | 594 | 0.390 |
Why?
|
Ultraviolet Rays | 2 | 2018 | 1099 | 0.380 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2021 | 4038 | 0.370 |
Why?
|
Homozygote | 1 | 2015 | 1774 | 0.350 |
Why?
|
Stem Cells | 4 | 2022 | 3539 | 0.340 |
Why?
|
Autoimmunity | 2 | 2022 | 1354 | 0.340 |
Why?
|
Epigenomics | 1 | 2015 | 959 | 0.330 |
Why?
|
Alopecia | 1 | 2024 | 415 | 0.330 |
Why?
|
Cicatrix, Hypertrophic | 2 | 2024 | 80 | 0.330 |
Why?
|
Lupus Erythematosus, Cutaneous | 2 | 2020 | 78 | 0.330 |
Why?
|
Pityriasis Rubra Pilaris | 2 | 2020 | 19 | 0.320 |
Why?
|
DNA Methylation | 9 | 2021 | 4425 | 0.310 |
Why?
|
Fluorescent Antibody Technique | 4 | 2024 | 2470 | 0.310 |
Why?
|
Fibroblasts | 1 | 2019 | 4161 | 0.300 |
Why?
|
Pemphigoid, Bullous | 2 | 2020 | 108 | 0.300 |
Why?
|
Immune Tolerance | 5 | 2023 | 2324 | 0.300 |
Why?
|
Immunohistochemistry | 8 | 2022 | 11007 | 0.290 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 903 | 0.290 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1888 | 0.280 |
Why?
|
Cell Differentiation | 5 | 2022 | 11641 | 0.270 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2882 | 0.260 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2024 | 3110 | 0.260 |
Why?
|
Cell Proliferation | 5 | 2019 | 10428 | 0.260 |
Why?
|
Humans | 95 | 2024 | 765734 | 0.260 |
Why?
|
Gene Expression Profiling | 5 | 2018 | 9522 | 0.250 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2018 | 195 | 0.240 |
Why?
|
Keratinocytes | 3 | 2019 | 862 | 0.240 |
Why?
|
Animals | 51 | 2024 | 168731 | 0.240 |
Why?
|
Lymph Nodes | 3 | 2024 | 3451 | 0.240 |
Why?
|
T-Lymphocytes | 8 | 2020 | 10262 | 0.240 |
Why?
|
Mice | 37 | 2024 | 81792 | 0.220 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2021 | 844 | 0.220 |
Why?
|
Receptor, Angiotensin, Type 1 | 3 | 2010 | 153 | 0.220 |
Why?
|
Receptors, Nerve Growth Factor | 2 | 2021 | 199 | 0.220 |
Why?
|
Complement Factor H | 1 | 2024 | 108 | 0.220 |
Why?
|
Neoplasm Metastasis | 6 | 2021 | 4885 | 0.220 |
Why?
|
Immunoconjugates | 5 | 2003 | 979 | 0.210 |
Why?
|
Immunoenzyme Techniques | 2 | 2017 | 1696 | 0.210 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2021 | 1118 | 0.210 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2822 | 0.200 |
Why?
|
Transplantation, Homologous | 9 | 2023 | 4858 | 0.200 |
Why?
|
Aldosterone | 3 | 2010 | 881 | 0.200 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 751 | 0.200 |
Why?
|
Interleukin-2 | 2 | 2024 | 1896 | 0.200 |
Why?
|
Male | 49 | 2024 | 363585 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2022 | 4642 | 0.190 |
Why?
|
Biopsy | 9 | 2021 | 6754 | 0.190 |
Why?
|
Angiotensin II | 3 | 2010 | 844 | 0.190 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11201 | 0.190 |
Why?
|
Retinal Degeneration | 2 | 2016 | 413 | 0.190 |
Why?
|
Myxoma | 1 | 2022 | 114 | 0.180 |
Why?
|
Skin Diseases | 2 | 2022 | 1080 | 0.180 |
Why?
|
Middle Aged | 31 | 2024 | 222903 | 0.180 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2023 | 2423 | 0.180 |
Why?
|
Antibodies, Monoclonal | 4 | 2018 | 9245 | 0.180 |
Why?
|
Uveal Neoplasms | 1 | 2024 | 343 | 0.180 |
Why?
|
Graft Survival | 8 | 2024 | 3890 | 0.180 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2019 | 182 | 0.180 |
Why?
|
Immunization, Passive | 1 | 2003 | 616 | 0.180 |
Why?
|
Limbus Corneae | 1 | 2022 | 144 | 0.180 |
Why?
|
Paget Disease, Extramammary | 1 | 2021 | 50 | 0.180 |
Why?
|
Genital Neoplasms, Male | 1 | 2021 | 68 | 0.180 |
Why?
|
Activating Transcription Factor 3 | 1 | 2020 | 61 | 0.170 |
Why?
|
Aged, 80 and over | 10 | 2021 | 59459 | 0.170 |
Why?
|
Penile Diseases | 1 | 2020 | 47 | 0.170 |
Why?
|
NG-Nitroarginine Methyl Ester | 3 | 2010 | 261 | 0.170 |
Why?
|
Angiomatosis | 1 | 2020 | 45 | 0.170 |
Why?
|
Scleroderma, Localized | 1 | 2020 | 84 | 0.170 |
Why?
|
Th1 Cells | 3 | 2016 | 1039 | 0.170 |
Why?
|
Pyoderma Gangrenosum | 1 | 2021 | 85 | 0.170 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2020 | 61 | 0.170 |
Why?
|
Fasciitis | 1 | 2020 | 66 | 0.170 |
Why?
|
Scrotum | 1 | 2020 | 115 | 0.170 |
Why?
|
Aged | 23 | 2024 | 171050 | 0.170 |
Why?
|
Epithelium, Corneal | 1 | 2022 | 246 | 0.160 |
Why?
|
Mutation | 5 | 2016 | 30184 | 0.160 |
Why?
|
Skin Diseases, Vascular | 1 | 2020 | 41 | 0.160 |
Why?
|
Edema | 1 | 2023 | 760 | 0.160 |
Why?
|
Keratin-15 | 1 | 2019 | 22 | 0.160 |
Why?
|
Ice | 1 | 2020 | 102 | 0.160 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3948 | 0.160 |
Why?
|
Intestines | 4 | 2006 | 1906 | 0.160 |
Why?
|
Paraneoplastic Syndromes | 1 | 2020 | 154 | 0.160 |
Why?
|
Female | 44 | 2024 | 395961 | 0.150 |
Why?
|
Liver | 1 | 2014 | 7559 | 0.150 |
Why?
|
Neural Crest | 1 | 2021 | 277 | 0.150 |
Why?
|
Melanosis | 1 | 2019 | 93 | 0.150 |
Why?
|
Dermatitis, Exfoliative | 1 | 2018 | 28 | 0.150 |
Why?
|
Immunosuppressive Agents | 8 | 2022 | 4207 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 2022 | 375 | 0.150 |
Why?
|
Growth Differentiation Factor 6 | 1 | 2017 | 8 | 0.150 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2018 | 139 | 0.150 |
Why?
|
Leukemic Infiltration | 1 | 2018 | 47 | 0.150 |
Why?
|
Mouth Mucosa | 1 | 2020 | 432 | 0.150 |
Why?
|
Adenylate Kinase | 1 | 2018 | 100 | 0.150 |
Why?
|
Models, Biological | 1 | 2014 | 9441 | 0.150 |
Why?
|
Mice, Inbred C3H | 7 | 2006 | 914 | 0.150 |
Why?
|
Up-Regulation | 3 | 2019 | 4136 | 0.140 |
Why?
|
Chemokines | 1 | 2022 | 956 | 0.140 |
Why?
|
Signal Transduction | 11 | 2021 | 23589 | 0.140 |
Why?
|
Melanins | 1 | 2019 | 291 | 0.140 |
Why?
|
Nasal Mucosa | 1 | 2020 | 416 | 0.140 |
Why?
|
Dermatomyositis | 1 | 2020 | 259 | 0.140 |
Why?
|
Mucous Membrane | 1 | 2020 | 656 | 0.140 |
Why?
|
Neoplasms | 8 | 2024 | 22345 | 0.140 |
Why?
|
Cells, Cultured | 5 | 2022 | 18972 | 0.140 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2015 | 148 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5693 | 0.140 |
Why?
|
Transplantation Tolerance | 2 | 2003 | 640 | 0.140 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2018 | 4405 | 0.140 |
Why?
|
Lichen Planus, Oral | 1 | 2017 | 56 | 0.140 |
Why?
|
Epidermis | 1 | 2019 | 535 | 0.130 |
Why?
|
Mycosis Fungoides | 1 | 2018 | 154 | 0.130 |
Why?
|
Subcutaneous Fat | 1 | 2020 | 401 | 0.130 |
Why?
|
Adult | 23 | 2024 | 222974 | 0.130 |
Why?
|
Cicatrix | 2 | 2020 | 797 | 0.130 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2016 | 55 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13639 | 0.130 |
Why?
|
Granuloma, Foreign-Body | 1 | 2016 | 41 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2839 | 0.130 |
Why?
|
Talc | 1 | 2016 | 48 | 0.130 |
Why?
|
Eosinophilia | 1 | 2020 | 555 | 0.130 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2016 | 201 | 0.130 |
Why?
|
Exanthema | 1 | 2020 | 500 | 0.130 |
Why?
|
Estradiol | 2 | 2008 | 1947 | 0.130 |
Why?
|
MutS Homolog 2 Protein | 1 | 2016 | 200 | 0.130 |
Why?
|
Antigens, Differentiation | 4 | 2001 | 919 | 0.130 |
Why?
|
Protective Agents | 1 | 2017 | 151 | 0.130 |
Why?
|
Adenoma, Sweat Gland | 1 | 2015 | 16 | 0.120 |
Why?
|
Fibroma | 1 | 2017 | 197 | 0.120 |
Why?
|
Ceramides | 1 | 2017 | 201 | 0.120 |
Why?
|
Tissue Donors | 2 | 2014 | 2393 | 0.120 |
Why?
|
Neisseriaceae Infections | 1 | 2014 | 5 | 0.120 |
Why?
|
Receptor, EphA3 | 1 | 2014 | 13 | 0.120 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 820 | 0.120 |
Why?
|
Genes, myb | 1 | 2014 | 18 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 618 | 0.120 |
Why?
|
Methyltransferases | 1 | 2018 | 373 | 0.120 |
Why?
|
Cryosurgery | 1 | 2020 | 479 | 0.120 |
Why?
|
Leukemia, Myeloid | 1 | 2018 | 696 | 0.120 |
Why?
|
Purpura Fulminans | 1 | 2014 | 21 | 0.120 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1143 | 0.120 |
Why?
|
Rats, Transgenic | 1 | 2014 | 70 | 0.120 |
Why?
|
Naphthalenes | 1 | 2015 | 197 | 0.120 |
Why?
|
Face | 1 | 2020 | 1028 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 2 | 2014 | 1959 | 0.120 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 544 | 0.110 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2538 | 0.110 |
Why?
|
Histocompatibility Testing | 1 | 2016 | 726 | 0.110 |
Why?
|
Facial Neoplasms | 1 | 2015 | 126 | 0.110 |
Why?
|
Mice, Nude | 5 | 2020 | 3614 | 0.110 |
Why?
|
Paracrine Communication | 1 | 2016 | 277 | 0.110 |
Why?
|
Bone Marrow Cells | 2 | 2016 | 2412 | 0.110 |
Why?
|
Facial Injuries | 1 | 2015 | 190 | 0.110 |
Why?
|
Interleukin-17 | 2 | 2020 | 921 | 0.110 |
Why?
|
Intestine, Small | 3 | 2001 | 1214 | 0.110 |
Why?
|
Immunoblotting | 1 | 2017 | 1643 | 0.110 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3593 | 0.110 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 183 | 0.110 |
Why?
|
Zebrafish | 2 | 2022 | 3034 | 0.110 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2016 | 904 | 0.110 |
Why?
|
Cell Movement | 3 | 2019 | 5192 | 0.110 |
Why?
|
Immunoprecipitation | 1 | 2016 | 871 | 0.110 |
Why?
|
Rats | 8 | 2024 | 23704 | 0.110 |
Why?
|
Interleukin-6 | 2 | 2022 | 3229 | 0.110 |
Why?
|
Proteinuria | 1 | 2006 | 606 | 0.110 |
Why?
|
Lymphedema | 1 | 2020 | 525 | 0.110 |
Why?
|
Trans-Activators | 3 | 2016 | 2850 | 0.110 |
Why?
|
Axilla | 1 | 2016 | 615 | 0.110 |
Why?
|
Consanguinity | 1 | 2015 | 460 | 0.110 |
Why?
|
Rats, Inbred F344 | 1 | 2014 | 822 | 0.110 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2017 | 479 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2018 | 2720 | 0.110 |
Why?
|
Liver Diseases | 1 | 2022 | 1303 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1220 | 0.110 |
Why?
|
Prognosis | 7 | 2018 | 29899 | 0.100 |
Why?
|
Kidney Diseases | 1 | 2024 | 2097 | 0.100 |
Why?
|
Melanocytes | 2 | 2015 | 503 | 0.100 |
Why?
|
Soft Tissue Infections | 1 | 2014 | 166 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2021 | 2878 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3446 | 0.100 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1048 | 0.100 |
Why?
|
Myocardium | 4 | 2010 | 4763 | 0.100 |
Why?
|
Mice, Inbred NOD | 3 | 2023 | 1837 | 0.100 |
Why?
|
Erythropoietin | 1 | 2017 | 716 | 0.100 |
Why?
|
Interferon-gamma | 3 | 2016 | 3159 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2017 | 1185 | 0.100 |
Why?
|
Matrix Metalloproteinases | 1 | 2014 | 392 | 0.100 |
Why?
|
Mice, Inbred C57BL | 15 | 2022 | 22321 | 0.100 |
Why?
|
Histones | 2 | 2014 | 2592 | 0.100 |
Why?
|
Immunotherapy | 5 | 2021 | 4752 | 0.100 |
Why?
|
Diet, Sodium-Restricted | 1 | 2013 | 291 | 0.090 |
Why?
|
Psoriasis | 1 | 2019 | 919 | 0.090 |
Why?
|
Lymphotoxin-alpha | 1 | 2001 | 94 | 0.090 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 745 | 0.090 |
Why?
|
Retina | 3 | 2017 | 2648 | 0.090 |
Why?
|
Heart | 3 | 2013 | 4417 | 0.090 |
Why?
|
Pedigree | 2 | 2016 | 4524 | 0.090 |
Why?
|
Mice, Inbred BALB C | 7 | 2017 | 6219 | 0.090 |
Why?
|
Needles | 1 | 2024 | 460 | 0.090 |
Why?
|
Dermatology | 1 | 2021 | 906 | 0.090 |
Why?
|
Models, Animal | 4 | 2021 | 2120 | 0.090 |
Why?
|
RNA, Untranslated | 1 | 2014 | 453 | 0.090 |
Why?
|
Retinal Diseases | 1 | 2017 | 702 | 0.090 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2006 | 58 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1105 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2016 | 504 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4106 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2024 | 81457 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2018 | 2051 | 0.080 |
Why?
|
Adiponectin | 2 | 2013 | 1120 | 0.080 |
Why?
|
Sodium, Dietary | 1 | 2013 | 426 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2014 | 727 | 0.080 |
Why?
|
Software | 1 | 2024 | 4459 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2010 | 707 | 0.080 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2016 | 700 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1883 | 0.080 |
Why?
|
Disease Models, Animal | 6 | 2019 | 18289 | 0.080 |
Why?
|
DNA Helicases | 1 | 2014 | 852 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2018 | 3605 | 0.080 |
Why?
|
Extremities | 1 | 2014 | 869 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2014 | 778 | 0.080 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1740 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3504 | 0.080 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 1644 | 0.080 |
Why?
|
Hydrogels | 1 | 2024 | 728 | 0.080 |
Why?
|
Cell Line, Tumor | 7 | 2019 | 17062 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3563 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4391 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1926 | 0.080 |
Why?
|
Th2 Cells | 2 | 2001 | 1075 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1761 | 0.070 |
Why?
|
Lymphocyte Activation | 4 | 2016 | 5501 | 0.070 |
Why?
|
Caveolin 1 | 1 | 2010 | 255 | 0.070 |
Why?
|
Young Adult | 6 | 2019 | 59852 | 0.070 |
Why?
|
Gene Expression | 2 | 2019 | 7584 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 5891 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2016 | 18061 | 0.070 |
Why?
|
Histone Demethylases | 1 | 2010 | 328 | 0.070 |
Why?
|
Collagen | 1 | 2016 | 2618 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1601 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1622 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2010 | 589 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3078 | 0.070 |
Why?
|
Regeneration | 1 | 2016 | 1517 | 0.070 |
Why?
|
Glucose | 1 | 2018 | 4334 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 3651 | 0.070 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11888 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 954 | 0.060 |
Why?
|
Surgical Flaps | 1 | 2015 | 1678 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2003 | 591 | 0.060 |
Why?
|
RNA Interference | 1 | 2014 | 2828 | 0.060 |
Why?
|
Antibodies | 2 | 2024 | 2416 | 0.060 |
Why?
|
Bone Marrow Transplantation | 2 | 2003 | 2729 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3431 | 0.060 |
Why?
|
Apoptosis | 5 | 2020 | 9511 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1663 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2024 | 1585 | 0.060 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2017 | 257 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39180 | 0.060 |
Why?
|
Complement C3d | 1 | 2024 | 21 | 0.060 |
Why?
|
NF-kappa B | 1 | 2003 | 2486 | 0.060 |
Why?
|
Heart Transplantation | 3 | 2003 | 3310 | 0.060 |
Why?
|
Stromal Cells | 2 | 2022 | 1330 | 0.050 |
Why?
|
Mice, Knockout | 6 | 2018 | 14445 | 0.050 |
Why?
|
RNA, Messenger | 7 | 2008 | 12769 | 0.050 |
Why?
|
Rats, Wistar | 3 | 2008 | 1885 | 0.050 |
Why?
|
CD40 Ligand | 2 | 2003 | 528 | 0.050 |
Why?
|
Receptors, Mineralocorticoid | 3 | 2010 | 167 | 0.050 |
Why?
|
Kidney | 2 | 2006 | 7066 | 0.050 |
Why?
|
Spironolactone | 1 | 2006 | 415 | 0.050 |
Why?
|
Busulfan | 1 | 2003 | 264 | 0.050 |
Why?
|
Laminin | 1 | 2024 | 404 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2014 | 5781 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4036 | 0.050 |
Why?
|
Cell Survival | 3 | 2017 | 5747 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 23 | 0.050 |
Why?
|
Phenotype | 2 | 2022 | 16706 | 0.050 |
Why?
|
Antigens, CD | 5 | 2003 | 4020 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 1206 | 0.050 |
Why?
|
Complement Activation | 1 | 2024 | 430 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 1 | 2003 | 561 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1600 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2021 | 107 | 0.050 |
Why?
|
STAT4 Transcription Factor | 2 | 2001 | 94 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2022 | 285 | 0.050 |
Why?
|
Down-Regulation | 2 | 2019 | 2926 | 0.050 |
Why?
|
Sunlight | 1 | 2022 | 336 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4900 | 0.040 |
Why?
|
Ovariectomy | 2 | 2008 | 611 | 0.040 |
Why?
|
Drug Eruptions | 1 | 2024 | 334 | 0.040 |
Why?
|
Oncogene Protein v-akt | 1 | 2020 | 130 | 0.040 |
Why?
|
Collagen Type I | 1 | 2024 | 616 | 0.040 |
Why?
|
STAT6 Transcription Factor | 2 | 2001 | 197 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2020 | 22224 | 0.040 |
Why?
|
Keratosis | 1 | 2020 | 80 | 0.040 |
Why?
|
Current Procedural Terminology | 1 | 2021 | 100 | 0.040 |
Why?
|
Aminopyridines | 1 | 2024 | 576 | 0.040 |
Why?
|
Histamine Antagonists | 1 | 2020 | 93 | 0.040 |
Why?
|
Acute Disease | 3 | 2018 | 7232 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4352 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2018 | 697 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8732 | 0.040 |
Why?
|
Pigmentation Disorders | 1 | 2020 | 105 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.040 |
Why?
|
Ear, External | 1 | 2020 | 164 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 484 | 0.040 |
Why?
|
Injections, Intraperitoneal | 2 | 2000 | 411 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 4417 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1144 | 0.040 |
Why?
|
Parotid Neoplasms | 1 | 2021 | 157 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2006 | 969 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2022 | 852 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 566 | 0.040 |
Why?
|
RNA | 2 | 2022 | 2717 | 0.040 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2233 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2020 | 340 | 0.040 |
Why?
|
Adipokines | 2 | 2013 | 308 | 0.040 |
Why?
|
Erythema | 1 | 2020 | 260 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 159 | 0.040 |
Why?
|
Administration, Topical | 1 | 2020 | 703 | 0.040 |
Why?
|
Sus scrofa | 1 | 2020 | 430 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2003 | 511 | 0.040 |
Why?
|
Phosphorylation | 2 | 2020 | 8279 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 2019 | 265 | 0.040 |
Why?
|
Cohort Studies | 2 | 2022 | 41631 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 682 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6952 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3595 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3784 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2014 | 16041 | 0.040 |
Why?
|
Melanoma-Specific Antigens | 1 | 2018 | 73 | 0.040 |
Why?
|
Upper Extremity | 1 | 2023 | 682 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 65180 | 0.040 |
Why?
|
Enzyme Stability | 1 | 2018 | 218 | 0.040 |
Why?
|
Phosphoserine | 1 | 2018 | 203 | 0.040 |
Why?
|
Pyrroles | 1 | 2024 | 1119 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 489 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2022 | 1009 | 0.040 |
Why?
|
Embryo, Nonmammalian | 1 | 2021 | 907 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2020 | 556 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8528 | 0.030 |
Why?
|
Adipose Tissue | 3 | 2016 | 3313 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8730 | 0.030 |
Why?
|
Spleen | 3 | 2006 | 2295 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12800 | 0.030 |
Why?
|
Oligodendroglioma | 1 | 2018 | 274 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7599 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 430 | 0.030 |
Why?
|
Pancreas | 1 | 2023 | 1698 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1727 | 0.030 |
Why?
|
Opsins | 1 | 2016 | 18 | 0.030 |
Why?
|
Peyer's Patches | 1 | 2006 | 120 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2020 | 621 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2021 | 1558 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1624 | 0.030 |
Why?
|
Adolescent | 4 | 2019 | 88781 | 0.030 |
Why?
|
Microscopy, Polarization | 1 | 2016 | 88 | 0.030 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 70 | 0.030 |
Why?
|
Neck | 1 | 2020 | 733 | 0.030 |
Why?
|
Estrogen Receptor beta | 1 | 2006 | 171 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10069 | 0.030 |
Why?
|
Base Sequence | 2 | 2016 | 12402 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8102 | 0.030 |
Why?
|
Atrophy | 1 | 2020 | 1629 | 0.030 |
Why?
|
Transcription Factors | 1 | 2014 | 12123 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9071 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 189 | 0.030 |
Why?
|
Intravitreal Injections | 1 | 2017 | 391 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1316 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2022 | 1936 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2006 | 2746 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2016 | 283 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 474 | 0.030 |
Why?
|
Head | 1 | 2020 | 925 | 0.030 |
Why?
|
Neisseria meningitidis | 1 | 2014 | 111 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 479 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2018 | 1752 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2570 | 0.030 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2016 | 203 | 0.030 |
Why?
|
Osteocytes | 1 | 2016 | 193 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2016 | 414 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1238 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9368 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5986 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 911 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 683 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1489 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5336 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2016 | 592 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2014 | 695 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 731 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2836 | 0.030 |
Why?
|
Triglycerides | 2 | 2013 | 2441 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15749 | 0.030 |
Why?
|
Testosterone | 1 | 2024 | 2495 | 0.030 |
Why?
|
Immunity, Cellular | 2 | 2014 | 1554 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 752 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 654 | 0.030 |
Why?
|
Transplantation, Heterotopic | 1 | 2003 | 175 | 0.030 |
Why?
|
Mice, Obese | 1 | 2013 | 417 | 0.030 |
Why?
|
Sirolimus | 1 | 2020 | 1544 | 0.030 |
Why?
|
Judgment | 1 | 2014 | 270 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3618 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2006 | 579 | 0.020 |
Why?
|
Monocytes | 1 | 2022 | 2594 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2015 | 455 | 0.020 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2001 | 9 | 0.020 |
Why?
|
Cytokines | 2 | 2022 | 7424 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2001 | 14 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2454 | 0.020 |
Why?
|
Computational Biology | 1 | 2024 | 3558 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1032 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2011 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1880 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1253 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 584 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1959 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2393 | 0.020 |
Why?
|
Child | 2 | 2019 | 80499 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 602 | 0.020 |
Why?
|
Reoperation | 1 | 2021 | 4294 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13614 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3273 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2006 | 5879 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1617 | 0.020 |
Why?
|
HLA Antigens | 1 | 2016 | 1338 | 0.020 |
Why?
|
Metformin | 1 | 2018 | 904 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6109 | 0.020 |
Why?
|
Endothelial Cells | 2 | 2016 | 3584 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2022 | 3683 | 0.020 |
Why?
|
Body Weight | 2 | 2013 | 4624 | 0.020 |
Why?
|
Obesity | 2 | 2013 | 13079 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 1998 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1352 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2046 | 0.020 |
Why?
|
Vascular Malformations | 1 | 2015 | 470 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2021 | 3606 | 0.020 |
Why?
|
Lymphocyte Transfusion | 1 | 2000 | 236 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2018 | 1392 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 899 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3910 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1856 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1409 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 2010 | 478 | 0.020 |
Why?
|
Adipocytes | 1 | 2016 | 1193 | 0.020 |
Why?
|
Cell Communication | 1 | 2016 | 1659 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4772 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4909 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2051 | 0.020 |
Why?
|
Time Factors | 4 | 2018 | 40066 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4255 | 0.020 |
Why?
|
Protein Kinase C-delta | 1 | 2008 | 115 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10846 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2036 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2000 | 827 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2141 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2001 | 651 | 0.020 |
Why?
|
Microcirculation | 1 | 2003 | 1280 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2918 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2006 | 2354 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 206 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2006 | 2143 | 0.020 |
Why?
|
Methylation | 1 | 2010 | 1075 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2008 | 281 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2328 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 663 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5772 | 0.020 |
Why?
|
Abdomen | 1 | 2003 | 1133 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1994 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2573 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3419 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2427 | 0.020 |
Why?
|
Streptozocin | 1 | 2006 | 189 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3717 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9548 | 0.020 |
Why?
|
Mice, SCID | 1 | 2000 | 2627 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2794 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8498 | 0.020 |
Why?
|
PPAR gamma | 1 | 2008 | 483 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1746 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 54795 | 0.010 |
Why?
|
DNA | 1 | 2018 | 7200 | 0.010 |
Why?
|
Osteopontin | 1 | 2006 | 304 | 0.010 |
Why?
|
Hypertrophy | 1 | 2006 | 561 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8038 | 0.010 |
Why?
|
HeLa Cells | 1 | 2010 | 3067 | 0.010 |
Why?
|
Systole | 1 | 2006 | 935 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4352 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10605 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12787 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9351 | 0.010 |
Why?
|
Isoantigens | 1 | 2006 | 562 | 0.010 |
Why?
|
Albuminuria | 1 | 2006 | 660 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 12238 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8703 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 13024 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6001 | 0.010 |
Why?
|
Transplantation | 1 | 2003 | 222 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18375 | 0.010 |
Why?
|
Decision Making | 1 | 2014 | 3964 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2003 | 609 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14637 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20120 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2008 | 2240 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5924 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12949 | 0.010 |
Why?
|
Leptin | 1 | 2008 | 1597 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3989 | 0.010 |
Why?
|
Jejunum | 1 | 2001 | 474 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6601 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6427 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13403 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74831 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17595 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3336 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4563 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 4472 | 0.010 |
Why?
|
Diet | 1 | 2013 | 8085 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2001 | 7849 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3737 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24279 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8533 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20667 | 0.010 |
Why?
|